Esperanza Naredo Selected Research

Esperanza Naredo Research Topics

25	Rheumatoid Arthritis 01/2022 - 04/2008
15	Synovitis 01/2022 - 11/2012
8	Inflammation (Inflammations) 01/2020 - 04/2008
5	Tenosynovitis 01/2017 - 09/2012
4	Pain (Aches) 01/2021 - 04/2008
3	Bursitis (Adhesive Capsulitis) 01/2022 - 10/2010
3	Psoriatic Arthritis 01/2022 - 11/2012
3	Gout 01/2018 - 03/2007
2	Ankylosing Spondylitis 01/2022 - 06/2015
2	Arthritis (Polyarthritis) 01/2022 - 11/2017
2	Knee Osteoarthritis 01/2021 - 05/2014
2	Enthesopathy 05/2015 - 01/2014
1	Systemic Scleroderma (Systemic Sclerosis) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Crystal Arthropathies 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Osteoarthritis 01/2022
1	Joint Diseases (Joint Disease) 10/2021
1	Hip Osteoarthritis (Coxarthrosis) 01/2021
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2021
1	Sjogren's Syndrome (Sjogren Syndrome) 04/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 04/2020
1	Xerostomia 04/2020
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 07/2019
1	Rheumatic Diseases (Rheumatism) 01/2018
1	Disease Progression 01/2018
1	Clinical Deterioration 09/2017
1	Parotitis (Parotiditis) 07/2014
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2014
1	Carpal Tunnel Syndrome 01/2014
1	Vasculitis (Vasculitides) 01/2014
1	Spondylarthropathies 10/2010
1	Necrosis 05/2010
1	Osteomyelitis 05/2008

8	Biological ProductsIBA 01/2022 - 04/2008
7	Antirheumatic Agents (DMARD)IBA 09/2018 - 03/2015
5	Infliximab (Remicade)FDA Link 01/2018 - 11/2012
5	Uric Acid (Urate)IBA 01/2018 - 03/2007
4	Pharmaceutical PreparationsIBA 01/2020 - 05/2015
3	GlucocorticoidsIBA 01/2022 - 01/2017
3	Adalimumab (Humira)FDA Link 01/2020 - 09/2015
3	Methotrexate (Mexate)FDA LinkGeneric 09/2018 - 03/2016
3	C-Reactive ProteinIBA 11/2012 - 04/2008
2	AutoantibodiesIBA 04/2020 - 07/2014
2	Rheumatoid FactorIBA 01/2018 - 01/2018
2	Abatacept (Orencia)FDA Link 10/2016 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 05/2014
1	Ligases (Synthetase)IBA 01/2022
1	secukinumabIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	4-hexyloxyaniline (HOA)IBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	Certolizumab Pegol FDA Link 09/2020
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 04/2020
1	Indicators and Reagents (Reagents)IBA 07/2019
1	Anti-Citrullinated Protein AntibodiesIBA 01/2019
1	baricitinibIBA 09/2018
1	Janus KinasesIBA 09/2018
1	Peptides (Polypeptides)IBA 01/2018
1	AntibodiesIBA 01/2018
1	Betamethasone (Celestone)FDA Link 01/2017
1	Rituximab (Mabthera)FDA Link 06/2016
1	Complement System Proteins (Complement)IBA 03/2015
1	diphosphoric acid (pyrophosphoric acid)IBA 01/2014
1	Tuberculin (PPD)IBA 09/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2008
1	Etanercept (Enbrel)FDA Link 04/2008
1	amsonic acid (DAS)IBA 04/2008
1	ametantrone (HAQ)IBA 04/2008
1	Calcium PyrophosphateIBA 03/2007

14	Therapeutics 10/2021 - 04/2008
4	Biological Therapy 09/2015 - 03/2015
3	Injections 01/2018 - 09/2017
2	Drug Tapering 01/2020 - 01/2018
1	Intra-Articular Injections 01/2018
1	Intramuscular Injections 01/2017
1	Activities of Daily Living (ADL) 09/2015
1	Punctures 01/2014